Dr. Kunwoo Lee is the Co-Founder and CEO of GenEdit. He received a PhD from UC Berkeley in the Department of Bioengineering. He is the inventor of several delivery technologies for CRISPR/Cas9, which have shown great potential to revolutionize the treatment of genetic disorders. He was named as a Forbes 30 under 30 in 2017 and was a Siebel Scholar in 2016.